Phase I – Initial human trials to test tolerability
Phase II – Clinical trials to test the efficacy (small group of patients)
Phase III – Clinical trials to test the efficacy of the new substance in comparison to current standard therapy (large patient groups)
Phase IV – Further studies and observations after the drug has been approved by the regulatory authorities
The table is constantly updated. If you would like to make the listing of your clinical protocols openly available to haemato-oncology patients in your clinic or practice, please do not hesitate to contact us: nfhpsch
HOPOS supports the idea of treating haemato-oncology patients through clinical protocols, as we believe it is essential to take steps forward in the research of new, more effective, and better tolerated drugs. This can only be achieved if enough patients agree to be treated in clinical protocols. Even the standard treatment that can currently be offered was developed through the participation of previous patients in clinical trials.´
Are you planning a clinical trial in Switzerland, and you have too few patients with the appropriate profile? Contact us! We can launch a broad and efficient appeal to our member organizations: nfhpsch